Stephen Hsu
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$2.7MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $2.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 18, 2026 | NIH | STTR Phase I EC16 Nanoparticles: Bridging Oral Health and Alzheimer's Prevention via FAST Nanotechnology | $500K | CAMELLIX, LLC |
| Sep 19, 2022 | NIH | STTR Phase I Feasibility study of novel hand hygiene formulations against bacterial spore infection | $267K | CAMELLIX, LLC |
| Jul 1, 2022 | NIH | STTR Phase I Novel Nasal Formulations Containing EC16 for Minimizing COVID-19-Associated Anosmia | $385K | CAMELLIX, LLC |
| Nov 29, 2019 | NIH | STTR Phase II Novel sanitizer/disinfectants against viral infections with long-lasting effect | $653K | CAMELLIX, LLC |
| Nov 27, 2018 | NIH | STTR Phase II Novel sanitizer/disinfectants against viral infections with long-lasting effect | $706K | CAMELLIX, LLC |
| Jan 23, 2017 | NIH | STTR Phase I Novel sanitizer against viral infections with long-lasting effect | $193K | CAMELLIX, LLC |
Peer ranks
Federal funding#789
Awards as PI#349
Patents#505
Companies
- CAMELLIX, LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.